CSPC Pharmaceutical Group Limited. - ADR
CSPCY
Get informed when a big investor buys or sells
+ FollowMarket Cap$12.67B
Close$
$1.94
55.8% downside
Current Fair Value
55.8% downsideOvervalued by 55.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $12.67 Billion |
|---|---|
| Enterprise Value | $7.34 Billion |
| Dividend Yield | $0.15 (3.34%) |
| Earnings per Share | $1.32 |
| Beta | 0.75 |
| Outstanding Shares | 2,881,316,000 |
Return
| Return on Equity | 13.00% |
|---|---|
| Return on Assets | 9.23% |
| Return on Invested Capital | 18.92% |
Valuation & Multiples
| P/E Ratio | 21.94 |
|---|---|
| PEG | -270.29 |
| Price to Sales | 0.34 |
| Price to Book Ratio | 0.34 |
| Enterprise Value to Revenue | 0.2 |
| Enterprise Value to EBIT | 0.95 |
| Enterprise Value to Net Income | 1 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$7.58 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data